Cost-consequence analysis of sitagliptin versus sulfonylureas as add-on therapy for the treatment of diabetic patients in Italy

por Lorenzoni, Valentina, Baccetti, Fabio, Genovese, Stefano, Torre, Enrico, Turchetti, Giuseppe
Publicado 2017

Gender difference in response predictors after 1-year exenatide therapy twice daily in type 2 diabetic patients: a real world experience

por Anichini, Roberto, Cosimi, Sabrina, Di Carlo, Alberto, Orsini, Paola, De Bellis, Alessandra, Seghieri, Giuseppe, Franconi, Flavia, Baccetti, Fabio
Publicado 2013

Time to Treatment Intensification in Patients Receiving DPP4 Inhibitors Versus Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective Cohort Study

por Roberto, Giuseppe, Girardi, Anna, Barone-Adesi, Francesco, Pecere, Alessandro, Ientile, Valentina, Bartolini, Claudia, Da Cas, Roberto, Spila-Alegiani, Stefania, Ferrajolo, Carmen, Francesconi, Paolo, Trifirò, Gianluca, Poluzzi, Elisabetta, Baccetti, Fabio, Gini, Rosa
Publicado 2022

Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

por Roberto, Giuseppe, Barone-Adesi, Francesco, Giorgianni, Francesco, Pizzimenti, Valeria, Ferrajolo, Carmen, Tari, Michele, Bartolini, Claudia, Da Cas, Roberto, Maggini, Marina, Spila-Alegiani, Stefania, Francesconi, Paolo, Trifirò, Gianluca, Poluzzi, Elisabetta, Baccetti, Fabio, Gini, Rosa
Publicado 2019